In ~ 18% of tumors, FOLR1 expression fell into the borderline range (65-85%).<h4>Conclusion</h4>Approximately half of the ovarian cancer patients in this multicenter Polish cohort demonstrated FOLR1 positivity. This evidence concerns the gene FOLR1 and ovarian cancer.